The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Innate immunity in diabetes and diabetic nephropathy
Open accessAbstract
The innate immune system includes several classes of pattern recognition receptors (PRRs), including membrane-bound Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs). These receptors detect pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) in the extracellular and intracellular space. Intracellular NLRs constitute inflammasomes, which activate and release caspase-1, IL-1β, and IL-18 thereby initiating an inflammatory response. Systemic and local low-grade inflammation and release of proinflammatory cytokines are implicated in the development and progression of diabetes mellitus and diabetic nephropathy. TLR2, TLR4, and the NLRP3 inflammasome can induce the production of various proinflammatory cytokines and are critically involved in inflammatory responses in pancreatic islets, and in adipose, liver and kidney tissues. This Review describes how innate immune system-driven inflammatory processes can lead to apoptosis, tissue fibrosis, and organ dysfunction resulting in insulin resistance, impaired insulin secretion, and renal failure. We propose that careful targeting of TLR2, TLR4, and NLRP3 signalling pathways could be beneficial for the treatment of diabetes mellitus and diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826
RetractedGut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice
Caricilli, A. M., Picardi, P. K., de Abreu, L. L., Ueno, M., Prada, P. O., Ropelle, E. R., Hirabara, S. M., Castoldi, Â., Vieira, P., Camara, N. O. S., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001212 · Cited by 282
RetractedRajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedChaperone Insufficiency Links TLR4 Protein Signaling to Endoplasmic Reticulum Stress*
Coope, A., Milanski, M., Arruda, A. P., Ignácio-Souza, L., Saad, M., Anhê, G., & Velloso, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315218 · Cited by 39
RetractedInternational Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Murphy, K., & Weaver, C. (2016) · W.W. Norton eBooks · doi:10.1201/9781315533247 · Cited by 2,258
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Kim, K.-A., Gu, W., Lee, I.-A., Joh, E.-H., & Kim, D.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047713 · Cited by 1,176
Adipokines in health and disease
Fasshauer, M., & Blüher, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.014 · Cited by 1,050
Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.026 · Cited by 960
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Lerner, A. G., Upton, J.-P., Praveen, P. V. K., Ghosh, R., Nakagawa, Y., Igbaria, A., Shen, S., Nguyen, V., Backes, B. J., Heiman, M., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.007 · Cited by 846
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Caruso, R., Warner, N., Inohara, N., & Núñez, G. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.010 · Cited by 830
Structural basis for signal transduction by the Toll/interleukin-1 receptor domains
Xu, Y., Tao, X., Shen, B., Horng, T., Medzhitov, R., Manley, J. L., & Tong, L. (2000) · Nature · doi:10.1038/35040600 · Cited by 818
Inflammation and the pathogenesis of diabetic nephropathy
Wada, J., & Makino, H. (2013) · Clinical Science · doi:10.1042/cs20120198 · Cited by 775
Self-citationOslowski, C. M., Hara, T., O'Sullivan-Murphy, B., Kanekura, K., Lu, S., Hara, M., Ishigaki, S., Zhu, L. J., Hayashi, E., Hui, S. T., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.005 · Cited by 675
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States
Saran, R., Li, Y., Robinson, B., Ayanian, J., Balkrishnan, R., Bragg-Gresham, J., Chen, J. T. L., Cope, E., Gipson, D., He, K., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.001 · Cited by 656
Soesatyo, M. H. (2012) · Jurnal Teknosains · doi:10.22146/teknosains.5992 · Cited by 652
Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity
Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., Hawn, T. R., Raines, E. W., & Schwartz, M. W. (2007) · Circulation Research · doi:10.1161/circresaha.106.142851 · Cited by 584
Role of Toll-Like Receptors in Pathogen Recognition
Janssens, S., & Beyaert, R. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.637-646.2003 · Cited by 574
Roca, H., Varsos, Z. S., Sud, S., Craig, M. J., Ying, C., & Pienta, K. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042671 · Cited by 569
Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
Enlimomab Acute Stroke Trial Investigators (2001) · Neurology · doi:10.1212/wnl.57.8.1428 · Cited by 544
Liu, K., Zhao, E., Ilyas, G., Lalazar, G., Lin, Y., Haseeb, M., Tanaka, K. E., & Czaja, M. J. (2015) · Autophagy · doi:10.1080/15548627.2015.1009787 · Cited by 529
Adipose Tissue Macrophages Promote Myelopoiesis and Monocytosis in Obesity
Nagareddy, P. R., Kraakman, M., Masters, S. L., Stirzaker, R. A., Gorman, D. J., Grant, R. W., Dragoljevic, D., Hong, E. S., Abdel-Latif, A., Smyth, S. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.029 · Cited by 509
Mechanisms of inflammasome activation: recent advances and novel insights
Vanaja, S. K., Rathinam, V. A. K., & Fitzgerald, K. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.009 · Cited by 499
Kleinridders, A., Schenten, D., Könner, A. C., Belgardt, B. F., Mauer, J., Okamura, T., Wunderlich, F. T., Medzhitov, R., & Brüning, J. C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.013 · Cited by 483
Toll-like receptors: Activation, signalling and transcriptional modulation
De Nardo, D. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.025 · Cited by 457
Saberi, M., Woods, N.-B., de Luca, C., Schenk, S., Lu, J. C., Bandyopadhyay, G., Verma, I. M., & Olefsky, J. M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.006 · Cited by 456
Inflammaging: disturbed interplay between autophagy and inflammasomes
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2012) · Aging · doi:10.18632/aging.100444 · Cited by 453
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Shahzad, K., Bock, F., Dong, W., Wang, H., Kopf, S., Kohli, S., Al-Dabet, M. M., Ranjan, S., Wolter, J., Wacker, C., et al. (2015) · Kidney International · doi:10.1038/ki.2014.271 · Cited by 411
Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
Panee, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.06.018 · Cited by 402
Jourdan, T., Godlewski, G., Cinar, R., Bertola, A., Szanda, G., Liu, J., Tam, J., Han, T., Mukhopadhyay, B., Skarulis, M. C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3265 · Cited by 388
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
Liu, Y., Yin, H., Zhao, M., & Lu, Q. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8402-y · Cited by 365
Inflammasomes: guardians of cytosolic sanctity
Lamkanfi, M., & Dixit, V. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00730.x · Cited by 361
Moran, A., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Greenbaum, C. J., Herold, K. C., Marks, J. B., Raskin, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60023-9 · Cited by 356
Poggi, M., Bastelica, D., Gual, P., Iglesias, M. A., Gremeaux, T., Knauf, C., Peiretti, F., Verdier, M., Juhan-Vague, I., Tanti, J. F., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0654-8 · Cited by 355
The Inflammasomes in Kidney Disease
Anders, H.-J., & Muruve, D. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080798 · Cited by 351
Bertrand, M. J. M., Doiron, K., Labbé, K., Korneluk, R. G., Barker, P. A., & Saleh, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.011 · Cited by 340
ER stress activates the NLRP3 inflammasome via an UPR-independent pathway
Menu, P., Mayor, A., Zhou, R., Tardivel, A., Ichijo, H., Mori, K., & Tschopp, J. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.132 · Cited by 322
Functions of NOD-Like Receptors in Human Diseases
Zhong, Y., Kinio, A., & Saleh, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00333 · Cited by 317
Endosomes are specialized platforms for bacterial sensing and NOD2 signalling
Nakamura, N., Lill, J. R., Phung, Q., Jiang, Z., Bakalarski, C., de Mazière, A., Klumperman, J., Schlatter, M., Delamarre, L., & Mellman, I. (2014) · Nature · doi:10.1038/nature13133 · Cited by 313
Freigang, S., Ampenberger, F., Weiss, A., Kanneganti, T.-D., Iwakura, Y., Hersberger, M., & Kopf, M. (2013) · Nature Immunology · doi:10.1038/ni.2704 · Cited by 307
TLR4 at the Crossroads of Nutrients, Gut Microbiota, and Metabolic Inflammation
Velloso, L. A., Folli, F., & Saad, M. J. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1100 · Cited by 306
Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance
Jia, L., Vianna, C. R., Fukuda, M., Berglund, E. D., Liu, C., Tao, C., Sun, K., Liu, T., Harper, M. J., Lee, C. E., et al. (2014) · Nature Communications · doi:10.1038/ncomms4878 · Cited by 294
Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
Owen, B. M., Mangelsdorf, D. J., & Kliewer, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.10.002 · Cited by 286
Finucane, O. M., Lyons, C. L., Murphy, A. M., Reynolds, C. M., Klinger, R., Healy, N. P., Cooke, A. A., Coll, R. C., McAllan, L., Nilaweera, K. N., et al. (2015) · Diabetes · doi:10.2337/db14-1098 · Cited by 281
Microbiota-Derived Compounds Drive Steady-State Granulopoiesis via MyD88/TICAM Signaling
Balmer, M. L., Schürch, C. M., Saito, Y., Geuking, M. B., Li, H., Cuenca, M., Kovtonyuk, L. V., McCoy, K. D., Hapfelmeier, S., Ochsenbein, A. F., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400762 · Cited by 274
de Zeeuw, D., Bekker, P., Henkel, E., Hasslacher, C., Gouni-Berthold, I., Mehling, H., Potarca, A., Tesar, V., Heerspink, H. J. L., & Schall, T. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00261-2 · Cited by 273
Li, J., Jie, H.-B., Lei, Y., Gildener-Leapman, N., Trivedi, S., Green, T., Kane, L. P., & Ferris, R. L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1215 · Cited by 246
Dalmas, E., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron-Wisnewsky, J., Lacroix-Desmazes, S., Bayry, J., Kaveri, S. V., Clément, K., et al. (2014) · Diabetes · doi:10.2337/db13-1511 · Cited by 240
Implication of inflammatory signaling pathways in obesity-induced insulin resistance
Tanti, J.-F., Ceppo, F., Jager, J., & Berthou, F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00181 · Cited by 239
Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., Denis, R. G. P., Cochez, P., Pierard, F., Castel, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6648 · Cited by 237
Wang, C., Pan, Y., Zhang, Q.-Y., Wang, F.-M., & Kong, L.-D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038285 · Cited by 232
Suganami, T., Mieda, T., Itoh, M., Shimoda, Y., Kamei, Y., & Ogawa, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.190 · Cited by 227
Leptin resistance in obesity: An epigenetic landscape
Crujeiras, A. B., Carreira, M. C., Cabia, B., Andrade, S., Amil, M., & Casanueva, F. F. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.05.003 · Cited by 221
NALP Inflammasomes: a central role in innate immunity
Martinon, F., Gaide, O., Pétrilli, V., Mayor, A., & Tschopp, J. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0079-y · Cited by 218
Inducible Toll‐like Receptor and NF‐κB Regulatory Pathway Expression in Human Adipose Tissue
Vitseva, O. I., Tanriverdi, K., Tchkonia, T. T., Kirkland, J. L., McDonnell, M. E., Apovian, C. M., Freedman, J., & Gokce, N. (2008) · Obesity · doi:10.1038/oby.2008.25 · Cited by 216
Kim, S.-M., Lee, S.-H., Kim, Y.-G., Kim, S.-Y., Seo, J.-W., Choi, Y.-W., Kim, D.-J., Jeong, K.-H., Lee, T.-W., Ihm, C.-G., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00637.2014 · Cited by 204
The role of TNF-α in diabetic nephropathy: Pathogenic and therapeutic implications
NAVARRO, J., & MORAFERNANDEZ, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.011 · Cited by 198
ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
Chen, K., Zhang, J., Zhang, W., Zhang, J., Yang, J., Li, K., & He, Y. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.009 · Cited by 197
Of inflammasomes and pathogens – sensing of microbes by the inflammasome
Bauernfeind, F., & Hornung, V. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201771 · Cited by 195
Tlr2 is critical for diet‐induced metabolic syndrome in a murine model
Himes, R. W., & Smith, C. W. (2010) · The FASEB Journal · doi:10.1096/fj.09-141929 · Cited by 192
Denou, E., Lolmède, K., Garidou, L., Pomie, C., Chabo, C., Lau, T. C., Fullerton, M. D., Nigro, G., Zakaroff‐Girard, A., Luche, E., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404169 · Cited by 191
NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
Zheng, F., Xing, S., Gong, Z., & Xing, Q. (2013) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2013.01.012 · Cited by 190
Lim, Y.-M., Lim, H., Hur, K. Y., Quan, W., Lee, H.-Y., Cheon, H., Ryu, D., Koo, S.-H., Kim, H. L., Kim, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5934 · Cited by 189
The complex immunological and inflammatory network of adipose tissue in obesity
Apostolopoulos, V., de Courten, M. P. J., Stojanovska, L., Blatch, G. L., Tangalakis, K., & de Courten, B. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500272 · Cited by 187
CD4 T cell differentiation in type 1 diabetes
Walker, L. S. K., & von Herrath, M. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12672 · Cited by 181
Pattern recognition receptors and the inflammasome in kidney disease
Leemans, J. C., Kors, L., Anders, H.-J., & Florquin, S. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.91 · Cited by 175
Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
Youm, Y.-H., Adijiang, A., Vandanmagsar, B., Burk, D., Ravussin, A., & Dixit, V. D. (2011) · Endocrinology · doi:10.1210/en.2011-1326 · Cited by 174
Kellermayer, R., Dowd, S. E., Harris, R. A., Balasa, A., Schaible, T. D., Wolcott, R. D., Tatevian, N., Szigeti, R. G., Li, Z., Versalovic, J. A., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-172205 · Cited by 172
Sensing of microbial molecular patterns by Toll‐like receptors
Song, D. H., & Lee, J. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01167.x · Cited by 168
Salmela, K., Wramner, L., Ekberg, H., Hauser, I., Bentdal, ?., Lins, L.-E., Isoniemi, H., B??ckman, L., Persson, N., Neumayer, H.-H., et al. (1999) · Transplantation · doi:10.1097/00007890-199903150-00015 · Cited by 164
Toll-like receptor 4 modulates skeletal muscle substrate metabolism
Frisard, M. I., McMillan, R. P., Marchand, J., Wahlberg, K. A., Wu, Y., Voelker, K. A., Heilbronn, L. K., Haynie, K. R., Muoio, B. M., Li, L., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00307.2009 · Cited by 163
TLR4 Activation Promotes Podocyte Injury and Interstitial Fibrosis in Diabetic Nephropathy
Ma, J., Chadban, S. J., Zhao, C. Y., Chen, X., Kwan, T., Panchapakesan, U., Pollock, C. A., & Wu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097985 · Cited by 160
New paradigms in inflammatory signaling in vascular endothelial cells
Xiao, L., Liu, Y., & Wang, N. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00182.2013 · Cited by 160
Biochemical regulation of the inflammasome
Dowling, J. K., & O'Neill, L. A. J. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.694844 · Cited by 154
Toll-like receptors, inflammation, metabolism and obesity
Fresno, M., Álvarez, R., & Cuesta, N. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.562514 · Cited by 151
Du, P., Han, H., Han, H., Zhen, J., Shang, J., Wang, X., Li, X., Shi, W., Tang, W., Bao, C., et al. (2013) · Kidney International · doi:10.1038/ki.2013.113 · Cited by 148
Pontillo, A., Brandão, L. A. C., Guimarães, R. L., Segat, L., Araújo, J., & Crovella, S. (2010) · Autoimmunity · doi:10.3109/08916930903540432 · Cited by 147
The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules
Mudaliar, H., Pollock, C. A., Komala, M. G., Chadban, S. J., Wu, H., & Panchapakesan, U. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2012 · Cited by 145
Devaraj, S., Tobias, P. S., Kasinath, B. S., Ramsamooj, R., Afify, A. M., & Jialal, I. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228924 · Cited by 142
Kim, S., Joe, Y., Jeong, S. O., Zheng, M., Back, S. H., Park, S. W., Ryter, S. W., & Chung, H. (2013) · Innate Immunity · doi:10.1177/1753425913508593 · Cited by 135
Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome
Mitroulis, I., Skendros, P., & Ritis, K. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.03.005 · Cited by 132
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy
Lin, M. Y., Yiu, W. H., Li, R. X., Wu, H., Wong, D. W. L., Chan, L. Y. Y., Leung, J. C. K., Lai, K. N., & Tang, S. C. W. (2013) · Kidney International · doi:10.1038/ki.2013.11 · Cited by 132
Nąckiewicz, D., Dan, M., He, W., Kim, R., Salmi, A., Rütti, S., Westwell-Roper, C. Y., Cunningham, A. M., Speck, M., Schuster, C., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3249-1 · Cited by 130
Cloning and Functional Expression of mCCR2, a Murine Receptor for the C-C Chemokines JE and FIC
Kurihara, T., & Bravo, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11603 · Cited by 129
Myeloid Differentiation Factor 88 (MyD88)-Deficiency Increases Risk of Diabetes in Mice
Hosoi, T., Yokoyama, S., Matsuo, S., Akira, S., & Ozawa, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012537 · Cited by 126
Diabetic Tubulopathy: An Emerging Entity
Tang, S. C. W., Leung, J. C. K., & Lai, K. N. (2011) · Contributions to nephrology · doi:10.1159/000325647 · Cited by 122
Kaur, H., Chien, A., & Jialal, I. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00319.2012 · Cited by 117
Schenten, D., Nish, S. A., Yu, S., Yan, X., Lee, H. K., Brodsky, I. E., Pasman, L., Yordy, B., Wunderlich, F. T., Brüning, J. C., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.10.023 · Cited by 116
Okla, M., Wang, W., Kang, I., Pashaj, A., Carr, T. P., & Chung, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677724 · Cited by 116
Solini, A., Menini, S., Rossi, C., Ricci, P. C., Santini, E., Fantauzzi, C. B., Iacobini, C., & Pugliese, G. (2013) · The Journal of Pathology · doi:10.1002/path.4237 · Cited by 113
Davis, J. E., Braucher, D. R., Walker‐Daniels, J., & Spurlock, M. E. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.12.008 · Cited by 109
The Role of TLR2 and 4-Mediated Inflammatory Pathways in Endothelial Cells Exposed to High Glucose
Mudaliar, H., Pollock, C. A., Ma, J., Wu, H., Chadban, S. J., & Panchapakesan, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108844 · Cited by 108
Verzola, D., Cappuccino, L., D’Amato, E., Villaggio, B., Gianiorio, F., Mij, M., Simonato, A., Viazzi, F. C., Salvidio, G., & Garibotto, G. (2014) · Kidney International · doi:10.1038/ki.2014.116 · Cited by 99
Sarkar, S. A., Kutlu, B., Velmurugan, K., Kizaka‐Kondoh, S., Lee, C. E., Wong, R., Valentine, A., Davidson, H. W., Hutton, J. C., & Pugazhenthi, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1331-x · Cited by 98
Hussey, S. E., Liang, H., Costford, S. R., Klip, A., DeFronzo, R. A., Sanchez-Avila, A., Ely, B., & Musi, N. (2012) · Bioscience Reports · doi:10.1042/bsr20120098 · Cited by 97
Kuo, L.-H., Tsai, P.-J., Jiang, M.-Z., CHUANG, Y.-M., Yu, L., Lai, K.-T. A., & Tsai, Y.-S. (2010) · Diabetologia · doi:10.1007/s00125-010-1931-5 · Cited by 94
Boini, K. M., Xia, M., Abais, J. M., Li, G., Pitzer, A. L., Gehr, T. W. B., Zhang, Y., & Li, P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.033 · Cited by 94
Renal Protective Effects of Toll-like Receptor 4 Signaling Blockade in Type 2 Diabetic Mice
Cha, J. J., Hyun, Y. Y., Lee, M. H., Kim, J. E., Nam, D. H., Song, H. K., Kang, Y. S., Lee, J. E., Kim, H. W., Han, J., et al. (2013) · Endocrinology · doi:10.1210/en.2012-2080 · Cited by 92
Induction of Innate Immune Response through TLR2 and Dectin 1 Prevents Type 1 Diabetes
Karumuthil‐Melethil, S., Perez, N., Li, R., & Vasu, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8323 · Cited by 91
Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy
Navarro‐González, J. F., Jarque, A., Muros, M., Fernández, C. M., & Garcı́a, J. G. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.005 · Cited by 89
Frazão, J. B., Errante, P. R., & Condino‐Neto, A. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0243-0 · Cited by 89
Nativel, B., Marimoutou, M., Thon-Hon, V. G., Gunasekaran, M., Andries, J., Stanislas, G., Planesse, C., Silva, C. R. D., Césari, M., Iwema, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076039 · Cited by 88
Isolated Toll-like Receptor Transmembrane Domains Are Capable of Oligomerization
Godfroy, J. I., Roostan, M., Moroz, Y. S., Korendovych, I. V., & Yin, H. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048875 · Cited by 87
Martínez-Micaelo, N., González‐Abuín, N., Pinent, M., Ardèvol, A., & Blay, M. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400370 · Cited by 86
IL-1β-Mediated Innate Immunity Is Amplified in the db/db Mouse Model of Type 2 Diabetes
O’Connor, J. C., Satpathy, A., Hartman, M. E., Horvath, E. M., Kelley, K. W., Dantzer, R., Johnson, R. W., & Freund, G. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4991 · Cited by 86
Gao, P., He, F.-F., Tang, H. R., Lei, C., Chen, S., Meng, X., Su, H., & Zhang, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/504761 · Cited by 84
Murumalla, R. K., Gunasekaran, M., Padhan, J. K., Bencharif, K., Gence, L., Festy, F., Césari, M., Roche, R., & Hoareau, L. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-175 · Cited by 83
Jialal, I., Major, A. M., & Devaraj, S. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.07.003 · Cited by 81
Pillon, N. J., Azizi, P., Li, Y. E., Liu, J., Wang, C., Chan, K. L., Hopperton, K. E., Bazinet, R. P., Heit, B., Bilan, P. J., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00611.2014 · Cited by 81
Gao, P., Meng, X., Su, H., He, F.-F., Chen, S., Tang, H. R., Tian, X., Fan, D., Wang, Y., Liu, J.-S., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.07.001 · Cited by 80
Asrih, M., Altirriba, J., Rohner‐Jeanrenaud, F., & Jornayvaz, F. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126364 · Cited by 77
Li, Y., Xu, S., Jiang, B., Cohen, R. A., & Zang, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067532 · Cited by 75
Role of Toll-like receptors in diabetic nephropathy
Mudaliar, H., Pollock, C. A., & Panchapakesan, U. (2014) · Clinical Science · doi:10.1042/cs20130267 · Cited by 75
Westwell-Roper, C. Y., Nąckiewicz, D., Dan, M., & Ehses, J. A. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.4 · Cited by 75
NLRPs , microbiota, and gut homeostasis: unravelling the connection
Zambetti, L. P., & Mortellaro, A. (2014) · The Journal of Pathology · doi:10.1002/path.4357 · Cited by 73
Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms
Roberts, R. L., van Rij, A. M., Phillips, L. V., Young, S. L., McCormick, S. P. A., Merriman, T. R., & Jones, G. T. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.043 · Cited by 72
NLRP3 and IL ‐1 β in macrophages as critical regulators of metabolic diseases
McGettrick, A. F., & O'Neill, L. A. J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12169 · Cited by 72
Kopp, A., Buechler, C., Bala, M., Neumeier, M., Schölmerich, J., & Schäffler, A. (2010) · Endocrinology · doi:10.1210/en.2009-1140 · Cited by 72
Prajapati, B., Jena, P. K., Rajput, P., Purandhar, K., & Seshadri, S. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140515112609 · Cited by 72
Li, M., Song, L., Gao, X., Chang, W., & Qin, X. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.4.021 · Cited by 70
Toll‐like receptor 5 in obesity: The role of gut microbiota and adipose tissue inflammation
Pekkala, S., Munukka, E., Kong, L., Pöllänen, E., Autio, R., Roos, C., Wiklund, P., Fischer‐Posovszky, P., Wabitsch, M., Alén, M., et al. (2015) · Obesity · doi:10.1002/oby.20993 · Cited by 69
Association of the Polymorphism for Toll‐like Receptor 2 with Type 1 Diabetes Susceptibility
Park, Y., Park, S.-K., Yoo, E., Kim, D., & SHIN, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1337.028 · Cited by 69
Gottlieb, P. A., Alkanani, A. K., Michels, A. W., Lewis, E. C., Shapiro, L., Dinarello, C. A., & Zipris, D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3864 · Cited by 67
Liu, P., Li, F., Qiu, M.-C., & He, L.-J. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.020 · Cited by 64
Yang, M., Gan, H., Shen, Q. X., Tang, W., Du, X., & Chen, D. (2011) · Inflammation · doi:10.1007/s10753-011-9374-9 · Cited by 63
Islet‐expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation
Krüger, B., Yin, N., Zhang, N., Yadav, A., Coward, W. R., Lal, G., Zang, W., Heeger, P. S., Bromberg, J. S., Murphy, B. T., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040601 · Cited by 60
Liu, F., Lu, W., Qian, Q., Qi, W., Hu, J., & Feng, B. (2012) · BioMed Research International · doi:10.1155/2012/373945 · Cited by 57
Toll Receptor Polymorphisms and Carotid Artery Intima-Media Thickness
Labrum, R. W., Bevan, S., Sitzer, M., Lorenz, M., & Markus, H. S. (2007) · Stroke · doi:10.1161/01.str.0000260184.85257.2b · Cited by 56
Ji, Y., Sun, S., Goodrich, J. K., Kim, H., Poole, A. C., Duhamel, G. E., Ley, R. E., & Qi, L. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.040 · Cited by 54
Innate immunity and its role in type 1 diabetes
Zipris, D. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283073a46 · Cited by 53
Toll-like Receptor Polymorphisms and Carotid Artery Intima-Media Thickness
Lepper, P. M., von Eynatten, M., Humpert, P. M., Triantafilou, M., & Triantafilou, K. (2007) · Stroke · doi:10.1161/strokeaha.107.487058 · Cited by 53
Alkanani, A. K., Hara, N., Lien, E., Ir, D., Kotter, C. V., Robertson, C. E., Wagner, B. D., Frank, D. N., & Zipris, D. (2013) · Diabetes · doi:10.2337/db13-1007 · Cited by 52
NOD1 activation induces innate immune responses and insulin resistance in human adipocytes
Zhou, Y.-J., Zhou, H., Li, Y., & Song, Y.-L. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.08.001 · Cited by 51
Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway
Saurus, P., Kuusela, S., Lehtonen, E., Hyvönen, M. E., Ristola, M. A., Fogarty, C. L., Tienari, J., Lassenius, M. I., Forsblom, C. M., Lehto, M. J., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.125 · Cited by 49
Shang, J., Wan, Q., Wang, X., Duan, Y., Wang, Z., Wei, X., Zhang, Y., Wang, H., Wang, R., & Yi, F. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.013 · Cited by 48
Bollyky, P. L., Bice, J. B., Sweet, I. R., Falk, B. A., Gebe, J. A., Clark, A., Gersuk, V. H., Aderem, A. A., Hawn, T. R., & Nepom, G. T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005063 · Cited by 48
Anders, H., & Lech, M. (2013) · Kidney International · doi:10.1038/ki.2013.122 · Cited by 48
Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis
Nussbaum, G. (2006) · International Immunology · doi:10.1093/intimm/dxl074 · Cited by 45
Sawa, Y., Takata, S., Hatakeyama, Y., Ishikawa, H. T., & Tsuruga, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097165 · Cited by 44
TLR2 signaling improves immunoregulation to prevent type 1 diabetes
Filippi, C. M., Ehrhardt, K., Estes, E. A., Larsson, P., Oldham, J. E., & von Herrath, M. G. (2011) · European Journal of Immunology · doi:10.1002/eji.200939841 · Cited by 44
Jitprasertwong, P., Jaedicke, K. M., Nile, C. J., Preshaw, P. M., & Taylor, J. J. (2013) · Cytokine · doi:10.1016/j.cyto.2013.10.008 · Cited by 40
TLR4 is required for the obesity-induced pancreatic beta cell dysfunction
Li, J., Chen, L., Zhang, Y., Zhang, W. J., Xu, W., Qin, Y., Xu, J., & Zou, D. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt092 · Cited by 39
Hardy, O. T., Kim, A., Ciccarelli, C., Hayman, L. L., & Wiecha, J. L. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2012.00098.x · Cited by 38
Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions
Takata, S., Sawa, Y., Uchiyama, T., & Ishikawa, H. T. (2013) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.13002 · Cited by 33
Li, J., Jin, C., Cleveland, J. C., Ao, L., Xu, D., Fullerton, D. A., & Meng, X. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-90 · Cited by 31
Oh, D., Kim, H. R., Lee, M., & Woo, Y. S. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000355740 · Cited by 31
Macrophage CGI-58 deficiency promotes IL-1β transcription by activating the SOCS3–FOXO1 pathway
Miao, H., Ou, J., Zhang, X., Chen, Y., Xue, B., Shi, H., Gan, L., Yu, L., & Liang, H. (2014) · Clinical Science · doi:10.1042/cs20140414 · Cited by 31
Karumuthil‐Melethil, S., Sofi, M. H., Gudi, R. R., Johnson, B. M., Pérez, N., & Vasu, C. (2014) · Diabetes · doi:10.2337/db14-1145 · Cited by 30
Kim, M. S., Choi, M., & Han, S. N. (2011) · Nutrition Research and Practice · doi:10.4162/nrp.2011.5.3.219 · Cited by 30
TLR Signalling and Adapter Utilization in Primary Human In vitro Differentiated Adipocytes
Brenner, C., Simmonds, R. E., Wood, S. H., Rose, V., Feldmann, M., & Turner, J. J. O. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02744.x · Cited by 24
Kiely, A. P., Robinson, A. A., McClenaghan, N. H., Flatt, P. R., & Newsholme, P. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0160 · Cited by 23
Liu, M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.165 · Cited by 21
Modulation of virus-induced innate immunity and type 1 diabetes by IL-1 blockade
Hara, N., Alkanani, A. K., Dinarello, C. A., & Zipris, D. (2013) · Innate Immunity · doi:10.1177/1753425913502242 · Cited by 18
Wan, Z., Durrer, C. G., Mah, D., Simtchouk, S., & Little, J. P. (2014) · Nutrition Research · doi:10.1016/j.nutres.2014.08.012 · Cited by 15
Samuvel, D. J., Jin, J., Sundararaj, K. P., Li, Y., Zhang, X., Lopes-Virella, M. F., & Huang, Y. Q. (2011) · Endocrinology · doi:10.1210/en.2011-1026 · Cited by 14
Gnudi, L. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv053 · Cited by 12
Schmidt, L., & Carrillo-Sepúlveda, M. A. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1688-2 · Cited by 11
Motta, V. N., Markle, J., Gulban, O., Mortin-Toth, S. M., Liao, K., Mogridge, J., Steward, C. A., & Danska, J. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1400913 · Cited by 10
Treatment of Autoimmune Diabetes by Inhibiting the Initial Event
Lee, M. (2013) · Immune Network · doi:10.4110/in.2013.13.5.194 · Cited by 8
Cited by
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease
Anders, H.-J., Huber, T. B., Isermann, B., & Schiffer, M. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0001-y · Cited by 796
Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis
Chung, K. W., Dhillon, P., Huang, S., Sheng, X., Shrestha, R., Qiu, C., Kaufman, B. A., Park, J., Pei, L., Baur, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.003 · Cited by 651
Interleukin-18 in Health and Disease
Yasuda, K., Nakanishi, K., & Tsutsui, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030649 · Cited by 563
Update of pathophysiology and management of diabetic kidney disease
Lin, Y.-C., Chang, Y.-H., Yang, S.-Y., Wu, K.-D., & Chu, T.-S. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.02.007 · Cited by 562
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Metadata
- Authors
- Wada, J., & Makino, H.
- Venue
- Nature Reviews Nephrology
- Published
- 2015-11-16
- Volume
- 12
- Issue
- 1
- Pages
- 13-26
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2191038342
- Cited by
- 427
- References
- 174
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.